Order results by:
| Issue | Title | |
| Vol 15, No 2 (2023) | The use of antidepressants in neurological practice | Abstract similar documents |
| V. A. Parfenov | ||
| "... Antidepressants are widely used in neurological practice, and their use in stroke, Alzheimer ..." | ||
| Vol 15, No 5 (2023) | Depressive disorders and their pharmacotherapy in routine clinical practice | Abstract similar documents |
| S. N. Mosolov, V. A. Parfenov, A. V. Amelin, V. E. Medvedev, V. D. Mendelevich, G. M. Usov, Yu. P. Sivolap, A. N. Bogolepova, E. A. Mkhitaryan, D. S. Petelin | ||
| "... . Current approaches to the diagnosis and treatment of depressive disorders in neurological and psychiatric ..." | ||
| Vol 7, No 1 (2015) | Antidepressants are selective serotonin neuronal reuptake inhibitors: 40-year history | Abstract similar documents |
| D. S. Danilov | ||
| "... The paper presents historical prerequisites for designing antidepressants from a group ..." | ||
| Vol 5, No 1 (2013) | Neurological aspects of urinary incontinence in the elderly | Abstract similar documents |
| Vladimir Anatolyevich Parfenov | ||
| "... or suffer from dementia or other neurological diseases. The ideas on the pathogenesis and manifestations ..." | ||
| Vol 1, No 2 (2009) | DEPRESSION IN CEREBROVASCULAR DISEASES | Abstract similar documents |
| T. G. Voznesenskaya | ||
| "... of cerebrovascular disease and recovery of neurological functions. There is a bilateral association between stroke ..." | ||
| Vol 10, No 4 (2018) | Serotonin and norepinephrine reuptake inhibitor antidepressants: a look through the prism of their 30-year history | Abstract similar documents |
| D. S. Danilov | ||
| "... the main stages of the design and clinical introduction of serotonin and norepinephrine reuptake inhibitor ..." | ||
| Vol 15, No 5 (2023) | Comparative analysis of the use of selective serotonin reuptake inhibitors during pregnancy and the postpartum period. Safety of sertraline | Abstract similar documents |
| E. A. Ushkalova, A. V. Ushkalova | ||
| "... , occurring in 14–23% of women. Antidepressants from the selective serotonin reuptake inhibitor (SSRI) group ..." | ||
| Vol 4, No 4 (2012) | Poststroke depression: prevalence, pathogenesis, diagnosis, and treatment | Abstract similar documents |
| Vladimir Anatolyevich Parfenov | ||
| "... antidepressants and selective serotonin reuptake inhibitors is noted to have a positive effect; there are data ..." | ||
| Vol 12, No 6 (2020) | Post-stroke depression and the abilities of antidepressants to enhance the effectiveness of neurorehabilitation | Abstract similar documents |
| S. V. Kotov, E. V. Isakova, Yu. V. Egorova | ||
| "... are selective serotonin reuptake inhibitors, the use of tricyclic antidepressants is possible. A number ..." | ||
| Vol 8, No 1 (2016) | The rationale for antidepressants in the treatment of schizophrenia: A modern view on the problem in the context of evidence-based medicine | Abstract similar documents |
| D. S. Danilov, D. O. Magomedova, M. E. Matsneva | ||
| "... The paper discusses whether antidepressant treatment is rational in schizophrenics. It analyzes ..." | ||
| Vol 4, No 2 (2012) | The efficacy and tolerability of paroxetine (adepress), an antidepressant from a group of selective serotonin reuptake inhibitors, in psychoautonomic syndrome within anxiety-depressive disorders | Abstract similar documents |
| T G Voznesenskaya, N M Fokina | ||
| "... a high clinical efficacy and antidepressant, anxiolytic, and autonomic stabilizing activities. Adepress ..." | ||
| Vol 15, No 2 (2023) | Diagnosis and therapy of obsessive-compulsive spectrum disorders in general medical and neurological practice | Abstract similar documents |
| D. S. Petelin, A. N. Gamirova, O. Yu. Sorokina, D. V. Troshina, S. A. Semin, M. Sh. Boltueva, B. A. Volel | ||
| "... in accordance with the principles of evidence-based medicine, and the use of selective serotonin reuptake ..." | ||
| Vol 12, No 2 (2020) | Investigation of the efficiency of various antidepressant replacement regimens in the development of SSRI-induced apathy syndrome | Abstract similar documents |
| V. E. Medvedev, R. A. Kardashyan, V. I. Frolova, A. M. Burno, S. V. Nekrasova, V. I. Salyntsev | ||
| "... Selective serotonin reuptake inhibitors (SSRI)-induced apathy syndrome occurs in 5–20% of patients ..." | ||
| Vol 11, No 2 (2019) | Pathogenesis, clinical features, and treatments of depression in Parkinson's disease | Abstract similar documents |
| I. V. Milyukhina | ||
| "... in the detection of depressive disorder in a patient with PD, to the choice of an antidepressant ..." | ||
| Vol 13, No 3 (2021) | Depression treatment in women and men with bipolar affective disorder: a comparative study | Abstract similar documents |
| N. A. Tyuvina, A. E. Stolyarova, V. V. Balabanova, K. M. Bunkova, E. N. Efremova | ||
| "... Objective: to compare depression treatment efficacy with and without antidepressants (ADs) in men ..." | ||
| Vol 7, No 4 (2015) | Neurological disorders in hypertensive patients | Abstract similar documents |
| N. V. Vakhnina, O. V. Milovanova, V. V. Grinyuk | ||
| "... in hypertension is damaged more often and earlier. Neurological complications due to hypertension are frequently ..." | ||
| Vol 14, No 1 (2022) | Drug-induced liver injury with cholestasis in the neurologist and psychiatric practice | Abstract PDF (Eng) similar documents |
| O. D. Ostroumova, E. V. Shikh, N. V. Shikh, T. M. Ostroumova, Y. A. Isaakyan | ||
| "... are antidepressants, both tricyclic (amitriptyline, imipramine) and selective serotonin reuptake inhibitors (SSRIs ..." | ||
| Vol 17, No 2 (2025) | Drug-induced dyskinesia when taking Fluvoxamine | Abstract similar documents |
| A. A. Katok, D. M. Khasanova, I. A. Khasanov | ||
| "... of antidepressants and antipsychotics prescribed and an increasing awareness of possible side effects. Fluvoxamine ..." | ||
| Vol 14, No 1 (2022) | Impact of different classes of antidepressants on sleep and wakefulness regulation in depression | Abstract similar documents |
| G. M. Usov, D. Yu. Kolomytsev, L. M. Lomiashvili | ||
| "... confirmed by polysomnography. Most antidepressants impair sleep, so drugs that help to restore sleep ..." | ||
| Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
| I. V. Miliukhina | ||
| "... . In this connection, the search for a safe and effective antidepressant for patients with PD is of particular ..." | ||
| Vol 15, No 5 (2023) | Diagnosis and treatment of depression according to the functional recovery paradigm | Abstract similar documents |
| G. M. Usov | ||
| "... Since the appearance of the first antidepressants, ideas about the goals of long-term treatment ..." | ||
| Vol 14, No 4 (2022) | Adherence to antidepressant therapy: clinical experience on the example of agomelatine | Abstract similar documents |
| N. N. Petrova | ||
| "... , highlights the issues of adherence to antidepressant therapy, investigation of the safety and efficacy ..." | ||
| Vol 11, No 4 (2019) | Metamorphopsia in neurological practice | Abstract similar documents |
| V. N. Grigoryeva, K. A. Mashkovich | ||
| Vol 9, No 4 (2017) | Neurological complications of alcoholism | Abstract similar documents |
| I. I. Nikiforov, M. M. Rakitin, A. G. Merkin, P. V. Aronov, G. P. Kostyuk, D. V. Savelyev, R. N. Isaev, A. V. Kazantsev, V. A. Priyatel, I. A. Nikiforov | ||
| "... pathological craving for alcohol. Neurological pathology in turn occurs with frequent exacerbations ..." | ||
| Vol 4, No 4 (2012) | Use of vitamin B 1 preparations with different solubility in fats/oils and aqueous media: Clinical and pharmacological aspects | Abstract similar documents |
| Galina Vladislavovna Ramenskaya, O A Petukhova, V V Smirnov | ||
| "... neurological diseases has been today registered on the Russian pharmaceutical market. The most used agents ..." | ||
| Vol 15, No 4 (2023) | Cerebral ischemic events in patients with infective endocarditis: results of a single center retrospective study | Abstract similar documents |
| D. A. Demin, A. A. Kulesh, S. T. Enginoev, V. V. Demetskaya, E. V. Demina, M. V. Lezhikov, E. I. Shaposhnikova, D. R. Stompel | ||
| Vol 17, No 3 (2025) | Neurological masks of post-COVID syndrome | Abstract similar documents |
| O. N. Voskresenskaya, A. A. Kulesh, N. V. Lebedeva, A. B. Lokshina, D. A. Grishina, А. V. Peretechikova, O. V. Kolokolov, V. A. Parfenov | ||
| "... diagnosis. Neurological manifestations of PCS may include cognitive impairment (CI), dizziness, headaches ..." | ||
| Vol 14, No 4 (2022) | SSRI-associated apathy in Alzheimer's disease: a case series | Abstract similar documents |
| D. S. Petelin, A. N. Gamirova, O. N. Voskresenskaya, B. A. Volel | ||
| "... of psychotropic drugs commonly prescribed for AD, such as antidepressants of the SSRI class, may themselves cause ..." | ||
| Vol 1, No 3-4 (2009) | MILGAMMA AND MILGAMMA COMPOSITUM IN THE TREATMENT OF NEUROLOGICAL DISEASES | Abstract similar documents |
| N. V. Pizova | ||
| "... High doses of B-group vitamins are currently used to treat a variety of neurological diseases ..." | ||
| Vol 3, No 2 (2011) | Use of cereton in neurological care | Abstract similar documents |
| Yu. A. Starchina | ||
| "... The paper gives the data of studies of the efficacy of choline alphoscerate in neurological care ..." | ||
| Vol 9, No 2 (2017) | Sensorineural hearing loss in neurological practice | Abstract similar documents |
| V. A. Parfenov, L. M. Antonenko | ||
| "... Sensorineural hearing loss (SHL) is one of the most common disorders in neurological practice ..." | ||
| Vol 6, No 4 (2014) | Neurological manifestations of calcific aortic stenosis | Abstract similar documents |
| I. V. Egorov | ||
| "... of neurological symptoms of the disease, such as vertigo and syncope. ..." | ||
| Vol 9, No 4 (2017) | Somatic depression with cognitive impairment in a female patient with hypertension | Abstract PDF (Eng) similar documents |
| B. A. Volel, D. V. Troshina | ||
| "... and antidepressants and psychotherapy. Of particular interest is the problem in the diagnosis and therapy ..." | ||
| Vol 14, No 4 (2022) | Neurological complications of infective endocarditis: 10 rules of patient management | Abstract similar documents |
| D. A. Demin, A. A. Kulesh, O. I. Vinogradov, V. V. Demetskaya, D. Y. Kozmin, S. T. Enginoev, E. V. Demina, E. V. Nikolaeva, E. I. Shaposhnikova, D. R. Stompel | ||
| "... points regarding the neurological aspects of the disease, which are formulated in ten rules. They cover ..." | ||
| Vol 5, No 3 (2013) | Comorbidity of chronic pain and depression in neurological patients | Abstract similar documents |
| Gyuzel Rafkatovna Tabeeva | ||
| "... effectiveness in these patients. When there is a multitude of neurological, somatic, and autonomic disorders ..." | ||
| Vol 2, No 3 (2010) | Dyscirculatory encephalopathy: algorithm for diagnosis and treatment in patients with arterial hypertension | Abstract similar documents |
| A. S. Kadykov, N. V. Shakhparonova | ||
| Vol 3, No 4 (2011) | Cerebral circulation, neurological and neuropsychological disorders in idiopathic arterial hypotension | Abstract similar documents |
| A. V. Fonyakin, V. Vl. Mashin, A. S. Atayan, V. V. Mashin, V. I. Ruzov | ||
| "... ) in relation to neurological and neuropsychological disorders. Patients and methods. Sixty-five patients (mean ..." | ||
| Vol 12, No 2 (2020) | The history of mianserin and mirtazapine: study of their neurochemical activity and determination of their position in the classification of antidepressants | Abstract similar documents |
| D. S. Danilov, Yu. G. Tyulpin, V. D. Morozova | ||
| "... and mirtazapine. The concept of the development of the antidepressant effect of these drugs, by stimulating ..." | ||
| Vol 10, No 4 (2018) | Approaches to therapy for depressions in neurology: prospects for the use of agomelatine | Abstract similar documents |
| D. V. Romanov, B. A. Volel, D. S. Petelin | ||
| "... This review provides information on prospects for using the antidepressant agomelatine ..." | ||
| Vol 11, No 1 (2019) | Antidepressant therapy in patients with cardiovascular diseases | Abstract similar documents |
| V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya | ||
| "... , and prognostic importance. Anti-antidepressant therapy promotes a more pronounced somatic stabilizing effect ..." | ||
| Vol 13, No 1 (2021) | Depression during the COVID-19 pandemic (analysis of clinical cases) | Abstract similar documents |
| I. Yu. Dorozhenok | ||
| "... available antidepressants have contributed to the achievement of high-quality remission, the increase ..." | ||
| Vol 13, No 2 (2021) | Anxiety and depression in COVID-19: treatment options | Abstract similar documents |
| V. E. Medvedev | ||
| "... in the antidepressant fluvoxamine. ..." | ||
| Vol 11, No 3 (2019) | The use of vortioxetine for the correction of depression in Parkinson's disease: an example of clinical cases | Abstract similar documents |
| I. V. Miliukhina | ||
| "... with identified depression receive timely treatment with antidepressants. PD complicated by depression ..." | ||
| Vol 6, No 4 (2014) | Somatization of anxiety disorders in the practice of a neurologist: Algorithms and approaches to differentiated treatment | Abstract similar documents |
| E. G. Mendelevich | ||
| "... by using selective antidepressants not always can solve diverse clinical problems. ..." | ||
| Vol 5, No 1 (2013) | Bipolar affective disorders: the specific features of the course and maintenance pharmacotherapy | Abstract similar documents |
| Nina Arkadyevna Tyuvina, V N Smirnova | ||
| Vol 5, No 1 (2013) | Depression therapy optimization at the present stage of development of psychopharmacology | Abstract similar documents |
| Dmitry Sergeyevich Danilov | ||
| "... with antidepressants and drugs from other pharmacological groups may be used is considered. Separate attention is paid ..." | ||
| Vol 4, No 1 (2012) | Post-stroke depression: scientifically substantiated approaches to choosing therapy | Abstract similar documents |
| Yulia Aleksandrovna Starchina | ||
| "... the clinical types of PSD, the results of trials of the efficacy of antidepressants in these patients ..." | ||
| Vol 3, No 1 (2011) | The differential diagnosis and treatment of depressive disorders in menopausal women | Abstract similar documents |
| N. A. Tyuvina | ||
| Vol 8, No 4 (2016) | NEUROLOGICAL DISORDERS IN PATIENTS WITH HYPERTENSION AND THEIR CORRECTION | Abstract similar documents |
| N. V. Vakhnina, O. V. Milovanova | ||
| "... Neurological disorders in hypertensive patients can be caused by both brain injury and concomitant ..." | ||
| Vol 12, No 5 (2020) | NMDA receptor antagonists in the treatment of neurological diseases | Abstract similar documents |
| I. S. Preobrazhenskaya | ||
| "... antagonists used to treat various neurological diseases: neurodegenerative dementias, vascular cognitive ..." | ||
| Vol 1, No 2 (2009) | METABOLIC CORRECTION OF NEUROLOGICAL COMPLICATIONS OF DIABETES MELLITUS | Abstract similar documents |
| S. A. Rumyantseva, V. A. Stupin, E. V. Silina, V. V. Mikhal'skiy, A. I. Perevedentsev, D. D. Ryzhova | ||
| "... and progression of neurological complications of diabetes mellitus are presented. The results of some ..." | ||
| Vol 15, No 5 (2023) | Review of the monograph by D.S. Danilov “History of antidepressants. Book one: Irreversible non-selective monoamine oxidase inhibitors” | Abstract PDF (Eng) similar documents |
| S. Yu. Tsirkin | ||
| Vol 5, No 2 (2013) | Generalized anxiety disorder: Differential diagnosis and treatment | Abstract similar documents |
| Tatyana Gratsiyevna Voznesenskaya | ||
| "... , etiology, and pathogenesis. Antidepressants from a group of selective serotonin reuptake inhibitors ..." | ||
| Vol 7, No 4 (2015) | The incidence of Arnold–Chiari malformation in neurological practice | Abstract similar documents |
| E. A. Kantimirova, N. A. Shnaider, M. M. Petrova, I. G. Strotskaya, N. E. Dutova, O. V. Alekseeva, E. A. Shapovalova | ||
| "... of ACM types 0 and 1 in outpatient neurological practice. Patients and methods. A total 2039 case ..." | ||
| Vol 11, No 4 (2019) | Digital technologies in the diagnosis and treatment of neurological diseases | Abstract similar documents |
| N. V. Petukhova, M. P. Farkhadov, M. V. Zamegrad, S. P. Grachev | ||
| "... image processing, as well as to the diagnosis of neurological diseases based on computer-aided analysis ..." | ||
| Vol 11, No 3 (2019) | Neurological complications of alcoholic disease and ways of their correction | Abstract similar documents |
| A. Yu. Emelyanova, O. E. Zinovyeva, S. R. Fedoseev, E. V. Misyuryaeva | ||
| "... muscles. The paper provides a brief overview of Russian and foreign literature on the neurological ..." | ||
| Vol 4, No 1 (2012) | Vertigo in neurological practice (common problems of diagnosis and treatment) | Abstract similar documents |
| Olga Vladimirovna Kosivtsova, M V Zamergrad | ||
| "... Most patients with vertigo seek neurological advice. In spite of the availability of current ..." | ||
| Vol 2, No 2 (2010) | Antiaggregant therapy in neurological practice: objectives and possibilities | Abstract similar documents |
| E. V. Portnyagina, A. F. Portnyagin | ||
| Vol 17, No 2 (2025) | 12-year experience of incobotulinumtoxinA use in neurological practice | Abstract similar documents |
| N. V. Kireeva, E. G. Bukreeva, D. S. Kireev | ||
| "... various neurological conditions. IncobotulinumtoxinA is a purified BoNT-A, free from complexing proteins ..." | ||
| Vol 9, No 1 (2017) | Comparison of the efficacy of the multimodal serotonergic antidepressants trazodone and vortioxetine in the treatment of patients with endogenous depression: A meta-analysis of double-blind randomized placebo-controlled trials | Abstract similar documents |
| D. S. Danilov | ||
| "... Selective serotonergic antidepressants with a miltimodal mechanism of action are a new group ..." | ||
| Vol 13, No 6 (2021) | Role of chondroitin sulfate in the regulation of neuroimmunoendocrine network interactions in patients with neurological symptoms in the post-covid period | Abstract similar documents |
| I. V. Sarvilina, O. A. Gromova, M. Yu. Maksimova, M. N. Sharov, Yu. S. Prokofyeva | ||
| Vol 13, No 5 (2021) | Pathobiochemical pathways of redox imbalance in the neurological long-term effects of COVID-19 and the role of chondroitin sulfate in the redox status restoration | Abstract similar documents |
| I. V. Sarvilina, O. A. Gromova, A. V. Naumov | ||
| "... neurological effects, main pathobiochemical mechanisms, and integrated circuits of redox status impairment ..." | ||
| Vol 14, No 3 (2022) | Acute and long-term neurological disorders in patients with coronavirus infection | Abstract PDF (Eng) similar documents |
| V. A. Parfenov, A. A. Kulesh | ||
| "... persistence of complaints and disorders after COVID-19 is regarded as post-COVID syndrome (PCS). Neurological ..." | ||
| Vol 13, No 3 (2021) | Heterogeneity of the mild cognitive impairment syndrome (specialized outpatient service data analysis) | Abstract similar documents |
| A. B. Lokshina, V. V. Zakharov, D. A. Grishina, N. N. Koberskaya, E. A. Mkhitaryan, S. I. Posohov, N. N. Yakhno | ||
| "... the features of mild CI (MCI) syndrome in patients with neurological disorders based on the specialized ..." | ||
| Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | Nervous system injury in alcoholic disease | Abstract similar documents |
| O. E. Zinovyeva, N. V. Vashchenko, O. E. Mozgovaya, T. A. Yanakaeva, A. Yu. Emelyanova | ||
| "... of etiotropic, pathogenetic, and symptomatic treatment for neurological manifestations of alcoholic disease ..." | ||
| Vol 8, No 2 (2016) | The role of frontal-subcortical circuits in the development of obsessive-compulsive disorders | Abstract similar documents |
| M. A. Kutlubaev | ||
| "... of neurosis-like symptoms of the OCD spectrum in neurological diseases. The development of OCD is associated ..." | ||
| Vol 10, No 3 (2018) | Posthypoxic encephalopathy in patients after cardiac surgery: etiological, pathogenetic, and clinical aspects (a literature review) | Abstract PDF (Eng) similar documents |
| T. M. Alekseeva, O. A. Portik, M. P. Topuzova | ||
| "... Post-hypoxic encephalopathy is a brain damage manifested by neurological, neuropsychiatric ..." | ||
| Vol 17, No 3 (2025) | Efficacy and safety of intravenous thrombolytic therapy in patients with ischemic stroke and mild neurological deficit | Abstract similar documents |
| M. R. Suleymanova, T. V. Danilova, D. R. Khasanova | ||
| "... stroke (IS). Almost half of IS patients present with a mild neurological deficit at onset, for which ..." | ||
| Vol 5, No 2 (2013) | Irritable bowel syndrome in a psychiatristxs practice (the problem of nosological independence) and a possibility of its treatment with antidepressants (in case of paroxetine efficacy) | Abstract similar documents |
| Dmitry Sergeyevich Danilov, V D Morozova, I G Korobkova, T V Lukyanova | ||
| "... attention is given to the possibility of using antidepressants. An observation of the efficacy of paroxetine ..." | ||
| Vol 16, No 4 (2024) | Aviandr is a new original drug for treating anxiety | Abstract similar documents |
| V. A. Parfenov | ||
| "... methods), selective serotonin reuptake inhibitors (SSRIs) and selective serotonin and norepinephrine ..." | ||
| 1 - 70 of 411 Items | 1 2 3 4 5 6 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
